XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Convertible Loans Payable
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Convertible Loans Payable

Note 10. Convertible Loans Payable

 

As of June 30, 2023 and December 31, 2022, the balance of convertible loans payable net of discount was $67,458 and $73,664, respectively.

 

During the year ended December 31, 2022, the Company issued one convertible loan in the aggregate amount of $178,000. The note bears interest at 8% per annum and all matured within one year. The conversion features in the note met the definition of a derivative and required bifurcation and liability classification, at fair value. The fair value of the derivative liability as of the date of issuance was $175,025 and was recorded as a discount of the notes.

 

During the year ended December 31, 2021, the Company issued two convertible loans in the aggregate amount of $404,000. The notes bear interest at 8% per annum and all mature within one year. On October 21, 2021, the Maturity Date of the $304,000 loan was extended from March 25, 2022 to April 21, 2022. The embedded beneficial conversion features in the notes meet the definition of a derivative and requires bifurcation and liability classification, at fair value. The fair value of the derivative liability as of the date of issuance was $746,672 and was recorded as a discount of the notes. During the year ended December 31, 2022, the remaining balance of these loans was fully repaid or converted.

    
   Amount 
Balance of notes payable, net on December 31, 2021  $176,703 
Issuances of debt   178,000 
Cash settlement of debt   (150,000)
Debt discount   (175,025)
Conversions   (50,000)
Amortization of debt discount   93,986 
Balance of notes payable, net on December 31, 2022   73,664 
Amortization of debt discount   43,157 
Balance of convertible loan payables, net of discounts on March 31, 2023 (Unaudited)   116,821 
Conversions   (93,000)
Amortization of debt discount   43,637 
Balance of convertible loan payables, net of discounts on June 30, 2023 (Unaudited)  $67,458 

 

Derivative Liability

 

The Company issued debts that consist of the issuance of convertible notes with variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock to be issued is based on the future price of the Company’s common stock. The number of shares of common stock issuable upon conversion of the promissory note is indeterminate. Due to the fact that the number of shares of common stock issuable could exceed the Company’s authorized share limit, the equity environment is tainted, and all additional convertible debentures and warrants are included in the value of the derivative liabilities. Pursuant to ASC 815-15 Embedded Derivatives, the fair values of the variable conversion options and warrants and shares to be issued were recorded as derivative liabilities on the issuance date and revalued at each reporting period.

 

Based on the various convertible notes described above, the fair value of applicable derivative liabilities on notes and change in fair value of derivative liability are as follows as of June 30, 2023 and December 31, 2022:

    
   Total 
Balance as of December 31, 2021  $354,160 
Change Due to Issuances   175,026 
Change due to exercise / redemptions   (110,507)
Change in fair value   (234,654)
Balance as of December 31, 2022   184,025 
Change in fair value   (30,593)
Balance as of March 31, 2023 (Unaudited)   153,432 
Change due to exercise / redemptions   (113,806)
Change in fair value   20,484 
Balance of derivative liability as of June 30, 2023 (Unaudited)  $60,110 

 

A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s derivative liabilities that are categorized within Level 3 of the fair value hierarchy for the periods ended June 30, 2023 and December 31, 2022 is as follows:

          
    June 30, 2023    December 31, 2022 
    (Unaudited)      
           
Stock price  $0.030.05   $0.04 – 0.19 
Exercise price  $0.02 – 0.03   $0.02 - 0.10 
Contractual term (in years)   0.330.58     0.681.00 
Volatility (annual)   108% – 208%   140% – 1,313%
Risk-free rate   4.64% – 5.47%   0.51% - 4.73%

   

The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations.

 

Financial Liabilities Measured at Fair Value on a Recurring Basis

 

Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities:

  

Schedule of financial liabilities measured on recurring basis                
   Fair Value measured at June 30, 2023 (Unaudited) 
   Quoted prices in   Significant other   Significant   Fair value at 
   active markets   observable inputs   unobservable inputs   June 30, 
   (Level 1)   (Level 2)   (Level 3)   2023 
Derivative liability  $—     $—     $60,110   $60,110 
Total  $—     $—     $60,110   $60,110 

 

  

   Fair value measured at December 31, 2022 
   Quoted prices in   Significant other   Significant   Fair value at 
   active markets   observable inputs   unobservable inputs   December 31 
   (Level 1)   (Level 2)   (Level 3)   2022 
Derivative liability  $—     $—     $184,025   $184,025 
Total  $—     $—     $184,025   $184,025 

 

There were no transfers between Level 1, 2 or 3 during the six months ended June 30, 2023 and 2022.

 

During the three and six months ended June 30, 2023 the Company recorded a loss of $20,484 and a gain of $10,109, respectively, and for the three and six months ended June 30, 2022, the Company recognized $0 and $243,653, respectively, from the change in fair value of derivative liability.